Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04229563 · ClinicalTrials.gov registry record
Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease
A clinical trial, sponsored by Angiodynamics.
- Completed
- Registry status
- 102
- Enrollment target
NCT04229563 is a clinical trial that has completed, run by Angiodynamics. The registered enrollment target is 102 participants.
The verdict
NCT04229563 has completed, sponsored by Angiodynamics.
- COMPLETED
- Registry status
- 102 participants
- Enrollment target
Study Summary
The PATHFINDER Registry is a prospective, non-randomized, single arm, multicenter observational study. This pilot registry is aimed to evaluate the performance (peri-procedural) and clinical outcomes (intermediate and long-term) of the AURYON Atherectomy System, within the initial launch phase of the product in the market.
Interventions
- DEVICE AURYON Atherectomy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2020-08-04 |
| Est. Completion | 2023-04-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04229563
The ClinicalTrials.gov registry entry for NCT04229563 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Angiodynamics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AURYON Atherectomy System is the first listed.
NCT04229563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04229563 about?
NCT04229563 is a clinical study titled "Post-Market Registry of AURYON Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease". The PATHFINDER Registry is a prospective, non-randomized, single arm, multicenter observational study. This pilot registry is aimed to evaluate the performance (peri-procedural) and clinical outcomes (intermediate and long-term) of the AURYON Atherectomy System, within the initial launch phase of th...
What is the current status of trial NCT04229563?
This trial is currently completed. The enrollment target is 102 participants. The study started on 2020-08-04. Estimated completion is 2023-04-17.
What interventions are being tested in trial NCT04229563?
The interventions under investigation include: AURYON Atherectomy System (DEVICE).
Who is sponsoring clinical trial NCT04229563?
This trial is sponsored by Angiodynamics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.